Drug
Naltrexone Implant
Naltrexone Implant: highest development phase Phase 1, developed by Akyso Therapeutics, LLC. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Akyso Therapeutics, LLC
Trials
| Drug | Phase | Indication |
|---|---|---|
| Naltrexone implant, 9.6 grams NCT07064564 | Phase 1 | Opioid Use Disorder |
Latest
No recent events.
Follow Naltrexone Implant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.